RxDoctor Payments Data

Michele Loor, MD

Surgical Critical Care · Minneapolis, MNNPI 1710146618

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Intuitive Surgical at 38.0% of the total. Reporting peaked in 2019 at $499 and has fallen 95.9% since, to $20 in 2025.

$826in general payments, 2019–2025

Across 14 payments — averaging $58.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$313
  • AbbVie$259
  • Davol Inc.$180
  • Medtronic$28
  • TEI Biosciences Inc$24
  • TELA Bio, Inc.$21
$24,520in research payments, 2019–2025

Across 1 payment — averaging $24,520 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$25K

What the payments were for

  • Food & beverage$826100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical4$313
AbbVie2$259
Davol Inc.2$180
Medtronic2$28
TEI Biosciences Inc2$24
TELA Bio, Inc.2$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few surgical critical care providers in Minnesotato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$48,557
Medicare patients
79
Services billed
223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acetaminophen-CodeineAcetaminophen With Codeine16$86

Paid to pharmacies, not to this prescriber.

Other surgical critical care in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →